Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 35, 2022 - Issue 6
105
Views
0
CrossRef citations to date
0
Altmetric
Case Studies

Safety and efficacy of ketamine-augmented electroconvulsive therapy in third trimester pregnancy complicated by COVID-19

, MSORCID Icon, , MD, , MD & , MD
Pages 874-875 | Received 07 Jun 2022, Accepted 21 Jul 2022, Published online: 08 Aug 2022

  • Zhdanava M, Pilon D, Ghelerter I, et al. The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States. J Clin Psychiat. 2021;82(2):2–3. doi:10.4088/jcp.20m13699.
  • Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698–709. doi:10.1097/01.AOG.0000116689.75396.5f.
  • Al-Harbi KS. Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Prefer Adher. 2012;6:369–388. doi:10.2147/PPA.S29716.
  • Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E. Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial. Psychiatry Res. 2005;137(1-2):1–10. doi:10.1016/j.psychres.2005.06.008.
  • Oats JN, Vasey DP, Waldron BA. Effects of ketamine on the pregnant uterus. Br J Anaesth. 1979;51(12):1163–1166. doi:10.1093/bja/51.12.1163.
  • Baghai TC, Möller HJ. Electroconvulsive therapy and its different indications. Dialog Clin Neurosci. 2008;10(1):105–117. doi:10.31887/DCNS.2008.10.1/tcbaghai.
  • Johnstone EC, Deakin JF, Lawler P, et al. The Northwick Park electroconvulsive therapy trial. Lancet. 1980;316(8208-8209):1317–1320. doi:10.1016/S0140-6736(80)92393-4.
  • Grote NK, Bridge JA, Gavin AR, Melville JL, Iyengar S, Katon WA. Meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction. Arch Gen Psychiat. 2010;67(10):1012–1024. doi:10.1001/archgenpsychiatry.2010.111.
  • Tran H, Robb AS. SSRI use during pregnancy. Semin Perinatol. 2015;39(7):545–547. doi:10.1053/j.semperi.2015.08.010.
  • Malhotra A, Yosh E, Xiong M. Propofol’s effects on the fetal brain for non-obstetric surgery. Brain Sci. 2017;7(8):107. doi:10.3390/brainsci7080107.
  • Soares de Moura R, Silva GA, Tano T, Resende AC. Effect of propofol on human fetal placental circulation. Int J Obstet Anesth. 2010;19(1):71–76. doi:10.1016/j.ijoa.2009.01.019.
  • Spodniaková B, Halmo M, Nosáľová P. Electroconvulsive therapy in pregnancy—a review. J Obstet Gynaecol. 2015;35(7):659–662. doi:10.3109/01443615.2014.990427.
  • Leighton BL, Cheek TG, Gross JB, et al. Succinylcholine pharmacodynamics in peripartum patients. Anesthesiology. 1986;64(2):202–205. doi:10.1097/00000542-198602000-00012.
  • Duan L, Ng A, Chen W, et al. β-blocker exposure in pregnancy and risk of fetal cardiac anomalies. JAMA Intern Med. 2017;177(6):885–887. doi:10.1001/jamainternmed.2017.0608.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.